- Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses
Junichi Eguchi et al, 2006, Cancer Research CrossRef - Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
Huilong Luo et al, 2020, Pharmaceutics CrossRef - Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Mahmoud S. Alghamri et al, 2021, Frontiers in Pharmacology CrossRef - Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
John S. Jarboe et al, 2007, Cancer Research CrossRef - Prioritization schema for immunotherapy clinical trials in glioblastoma
Tiffany R. Hodges et al, 2016, OncoImmunology CrossRef - Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
Andrea Franson et al, 2022, Frontiers in Medicine CrossRef